RSLS - ReShape Lifesciences spikes as FDA clears new weight loss option
2023-12-13 06:46:06 ET
More on ReShape Lifesciences
- ReShape Lifesciences Inc. (RSLS) Q3 2023 Earnings Call Transcript
- Johnson & Johnson sees GLP-1 impact on weight loss surgeries
- Seeking Alpha’s Quant Rating on ReShape Lifesciences
- Historical earnings data for ReShape Lifesciences
- Financial information for ReShape Lifesciences
For further details see:
ReShape Lifesciences spikes as FDA clears new weight loss option